NCT00265070View on ClinicalTrials.gov

Trial of Iressa in Prostate Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

August 31, 2011

Conditions

Prostate Cancer

Interventions

DRUG

Gefitinib

250 mg tablet oral daily dose

Trial Locations (4)

Unknown

Research Site, Vancouver

Research Site, London

Research Site, Toronto

Research Site, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY